Spinal Fusion News and Research RSS Feed - Spinal Fusion News and Research

Centinel Spine reports FDA clearance and first surgical implantation of ALTOS system

Centinel Spine reports FDA clearance and first surgical implantation of ALTOS system

Centinel Spine, Inc., announces the U.S. Food and Drug Administration clearance of ALTOS, a posterior cervical thoracic stabilization system indicated for use in either the lateral masses of the cervical spine or the pedicles of the cervical-thoracic spine. The first surgical implantation of the ALTOS system was performed by Gery Hsu, MD, CRMC Medical Associates, Coffeyville, KS on January 4, 2016. [More]
Combining NELL-1 with BMP2 therapy may promote bone development

Combining NELL-1 with BMP2 therapy may promote bone development

Bone morphogenetic protein-2 (BMP2) is used clinically to promote bone repair. However, the high BMP2 concentrations required to stimulate bone growth in humans may produce life-threatening adverse effects such as cervical swelling in spinal fusion procedures, a problem that prompted an FDA warning in 2008. [More]
Novel technology can improve quality of life for children with scoliosis

Novel technology can improve quality of life for children with scoliosis

Scoliosis - typically defined as the curvature of the spine— affects around 3 out of every 100 people. While most cases of scoliosis are mild, some children develop spine deformities that continue to get more severe as they grow. An especially severe spinal curve can reduce the amount of space within the chest, making it difficult for the lungs to function properly. [More]
Health insurance coverage for transgender people is cost-effective, study finds

Health insurance coverage for transgender people is cost-effective, study finds

A new analysis led by the Johns Hopkins Bloomberg School of Public Health suggests that while most U.S. health insurance plans deny benefits to transgender men and women for medical care necessary to transition to the opposite sex, paying for sex reassignment surgery and hormones is actually cost-effective. [More]
New study refutes increased cancer risk for patients undergoing spinal fusion surgery with rhBMP

New study refutes increased cancer risk for patients undergoing spinal fusion surgery with rhBMP

A new study may alleviate concerns regarding increased cancer risk for patients undergoing spinal fusion surgery with recombinant human bone morphogenetic protein (rhBMP). The study appears in November 15 issue of Spine, published by Wolters Kluwer. [More]
Interventional Spine receives FDA clearance for Opticage Expandable Interbody Fusion Device

Interventional Spine receives FDA clearance for Opticage Expandable Interbody Fusion Device

Interventional Spine, Inc. today announced the FDA clearance of their next generation Opticage Expandable Interbody Fusion Device. The next generation system is an enhanced version of the original Opticage system that was introduced in 2012. [More]
Novartis’ Cosentyx® show no progression in spinal damage in 80% of ankylosing spondylitis patients

Novartis’ Cosentyx® show no progression in spinal damage in 80% of ankylosing spondylitis patients

Novartis announced today late-breaking two year results for Cosentyx® (secukinumab) showing up to 80% of patients with ankylosing spondylitis (AS) had no radiographic progression in the spine on x-ray assessment. This is the first time that data on structural spinal progression in AS have been presented for an interleukin-17A (IL-17A) inhibitor. [More]
Biodegradable polymer could help heal the bones of patients with orthopedic injuries

Biodegradable polymer could help heal the bones of patients with orthopedic injuries

A plastic derived from cornstarch combined with a volcanic ash compound, Montmorillonite clay, could help heal the bones of hundreds of thousands of patients with orthopedic injuries who need bone replacement after tumor removal, spinal fusion surgery or fracture repair. [More]

Nanovis announces availability of new FortiCore interbody fusion devices

Nanovis, a life sciences company committed to developing scientifically advanced regenerative platforms for implantable medical devices, today announced the availability of the FortiCore wedge shaped lordotic cervical cage and a transforaminal lumbar interbody fusion (TLIF) device with increased scaffolding. [More]

Amedica launches innovative articulating inserter for minimally invasive TLIF procedures

Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce the release of its Scorpion™ articulating inserter to accompany the Valeo II™ TL interbody fusion device system. The Scorpion inserter will be commercially available mid-November 2015, and will aide in minimally-invasive transforaminal lumbar interbody fusion surgeries. [More]
DePuy Synthes Spine launches new all-in-one pedicle screw system to help simplify spinal surgery

DePuy Synthes Spine launches new all-in-one pedicle screw system to help simplify spinal surgery

DePuy Synthes Spine has introduced the EXPEDIUM VERSE Spinal System, a new all-in-one pedicle screw system. The system enables surgeons to perform multiple spinal correction maneuvers during spinal fusion surgery with a single implant type and fewer instruments, compared to traditional pedicle screw systems. [More]

Dynamic spine brace in development for children with scoliosis

Some six million people in the U.S. suffer from scoliosis, a sideways curvature of the spine. These include approximately 2 to 3% of adolescents who are diagnosed each year with idiopathic scoliosis, which is usually identified during puberty and progresses until skeletal maturity. [More]

Researchers developing dynamic spine brace for children with scoliosis

Some six million people in the U.S. suffer from scoliosis, a sideways curvature of the spine. These include approximately 2 to 3% of adolescents who are diagnosed each year with idiopathic scoliosis, which is usually identified during puberty and progresses until skeletal maturity. [More]
Costs for spinal fusion vary substantially by region, shows new research

Costs for spinal fusion vary substantially by region, shows new research

Costs for spinal fusion vary substantially by region, with costs being lowest in the Midwest and highest in the Northeast, according to the new research by Dr. W. Ryan Spiker and colleagues of University of Utah, Salt Lake City. [More]

Amedica announces release of Valeo II LL interbody fusion device

Amedica Corporation, an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, is pleased to announce the release of its silicon nitride lateral lumbar interbody fusion device. [More]
Novel wound closure technique may reduce complication rates for patients with scoliosis

Novel wound closure technique may reduce complication rates for patients with scoliosis

Patients with scoliosis who undergo surgery may be less likely to develop an infection or other complications after the procedure when a novel wound closure technique pioneered at NYU Langone Medical Center is utilized, according to new research. [More]
FDA grants first cervical multilevel indication to Centinel Spine’s STALIF C integrated interbody device

FDA grants first cervical multilevel indication to Centinel Spine’s STALIF C integrated interbody device

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile, Integrated Interbody fusion devices was granted the first cervical multilevel indication for a Stand-Alone interbody device by the U.S. Food and Drug Administration (FDA). [More]
Innovative business ideas presented at PolyU Innovation and Entrepreneurship GSC 2015

Innovative business ideas presented at PolyU Innovation and Entrepreneurship GSC 2015

Organized by The Hong Kong Polytechnic University, PolyU Innovation and Entrepreneurship Global Student Challenge (GSC) 2015 has come to a fruitful close. [More]

Centinel Spine obtains FDA clearance for STALIF MIDLINE, MIDLINE II and MIDLINE II-Ti devices

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile, Integrated Interbody fusion devices receive FDA clearance for its STALIF MIDLINE, MIDLINE II, MIDLINE II-Ti (Ti-ACTIVE) devices for use with allogeneic bone graft in lumbar spinal fusion procedures. [More]
MIS TLIF surgery results in less pain, shorter hospital stay and faster recovery

MIS TLIF surgery results in less pain, shorter hospital stay and faster recovery

A minimally invasive spinal fusion back surgery results in less blood loss, less postoperative pain, smaller incisions, a shorter hospital stay and faster recovery and return to work. [More]
Advertisement
Advertisement